Roche’s Evrysdi granted USFDA priority review for treatment of spinal muscular atrophy
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Closing the Loop on single-use plastics
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise
The covid health center will be managed and administered by the district administration of Ballari
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
The tablet donations provided for the treatment of more than 600 million schoolchildren in affected countries in sub-Saharan Africa since 2007
The company has been manufacturing masks since the Covid-19 outbreak in 2020
The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases
Subscribe To Our Newsletter & Stay Updated